Collaborative Stage. Site-Specific Instructions - LUNG

Size: px
Start display at page:

Download "Collaborative Stage. Site-Specific Instructions - LUNG"

Transcription

1 Slide 1 Collaborative Stage Site-Specific Instructions - LUNG In this presentation, we are going to review the AJCC Cancer Staging criteria for the lung primary site. Slide 2 Reading Assignments As each data item is being discussed, you should stop and read the information in CSv2 Part II for the lung and CSv2 Part I, Section 2 for that data item including the associated notes, codes and definitions. 2 It is important that you follow along and make notes in your manual. In addition to reading the slides and the instructor s notes, it is important that you stop and read the related sections in your manual as not every point will be discussed in detail. As we go through each data item, don t forget the general rules. They still apply. These will not be discussed in detail. Only those things that are specific to the lung schema will be discussed. Also, don t forget about the information you learned in the AJCC presentation, such as the discussions on hilar versus hilum, clinical findings that are often missed, and pleural effusions. These concepts apply to CS as well.

2 Slide 3 CS Lung Schema CS TS/Ext Eval CS Lymph Nodes Eval CS Reg LN Pos CS Reg LN Exam CS Mets Eval Refer to the General Rules Refer to the CS Breast presentation 3 As we discuss each site specific schema, many of the concepts are the same throughout and do not need to be repeated. The data items listed on this slide will not be discussed again. These data items follow the general rules and do not differ from the discussion provided in the CS Breast presentation. For the Eval fields, refer to the clinical and pathologic staging criteria in the AJCC manual and in the AJCC Lung presentation for the procedures that qualify for each eval code. Also, for those data items that are discussed, many of the concepts for the general rules will not be repeated. The presentation will focus on those areas specific for the lung.

3 Slide 4 CS Tumor Size Records the largest dimension or diameter of the primary tumor Needed to assign the AJCC T category in certain cases Special Codes for the Lung: 996 Occult carcinoma. No visible tumor, but malignant cells in sputum (CS Extension Code 980) 997 Diffuse tumor involving entire lobe 998 Diffuse tumor involving entire lung. Diffuse, NOS Do not code size of hilar mass unless the primary tumor is stated to be in the hilum 4 For the most part, the tumor size for the lung follows the general rules for this data item. There are a few codes that have a description that applies specifically to the lung. For example, if they do a sputum cytology that contained malignant cells, but the radiology was negative for tumor, then assign the tumor size as 996. These occult tumors will also have a CS Extension code of 980. These special codes have priority over the other codes. And, following through from our discussion on hilar versus hilum in the AJCC presentation, the description of hilar can be describing either the primary tumor or lymph node involvement. Only code the size of the hilar mass if it stated to be the primary tumor and not the lymph node mass. The tumor size is needed to derive the AJCC T category in certain instances. Avoid coding unknown if at all possible.

4 Slide 5 CS EXTENSION - LUNG Contiguous (direct) extension of the primary tumor Within the organ of origin or Directly into neighboring organs Code the farthest documented extension of the primary tumor. Do not include discontinuous (separate) metastases to distant sites. These are coded in CS Mets at Dx 5 In the CS Extension, we are going to document how far the primary tumor has directly extended into the surrounding tissues, organs, or other structures. If there is a separate site of tumor, it is not a factor in this data item. Use the CS Mets at DX field.

5 Slide 6 CS EXTENSION NOTE 1 Direct extension to or involvement of these structures is coded in the data item CS Mets at DX. CS Mets Code 23 D.E. to Contralateral Lung D.E. to Contralateral MSB Separate Tumor Nodule(s) in Contralateral lung CS Mets Code 37 Sternum Skeletal Muscle Skin of Chest CS Mets Code 40 Rib 6 Use CS Extension Code 730 when there is direct extension from the primary tumor into an adjacent rib. There are a few exceptions. There are a few neighboring structures that are NOT included in the CS Extension data item. They are listed here on the slide and in Note 1. If there is direct extension into these structures, then it is coded in the CS Mets at Dx data item. Look at the CS Extension code 730. To use code 730, there has to be direct extension from the primary tumor into an adjacent rib (which means it has to be on the same side as the involved lung). If it is a completely separate tumor in the rib, then it is coded in CS Mets at Dx, code 40.

6 Slide 7 CS Extension Local (T1 or T2) B E A F D C (D) Code 110 Superficial bronchus only, any TS (E) Code 230 Confined to hilus; need TS (F) Code 250 Confined to carina; need TS Code 300 Localized, NOS 7 CS Extension Code 100 Confined to Lung, need TS (A) Tumor surrounded by lung (B) Or by visceral pleura; (C) No invasion more proximal than a lobar bronchus The next few slides show a comparison of what AJCC T category will be derived based on what you entered in the CS Tumor Size and CS Extension data items. Note that it takes both fields to derive the T for many codes, so avoiding unknowns in both of these is very important. A tumor size of more than or less than 3cm is the deciding factor as to whether these are a T1 or a T2. To use a code 100 (tumors A-C), it has to be completely surrounded by lung tissue or the visceral pleura. It can extend into a lobar bronchus but no farther. Most cases surrounded by normal tissue are coded to 100. Do not code superficial tumors as code 100. Superficial lung tumors of any size are coded to 110 (D). Superficial tumors are located near the surface of the lung and minimally invasive, and the invasion is limited to the bronchial wall. The tumor in the hilum (E) in this picture looks like it is in the middle of the upper lobe, but if you will remember the side view of the lung, this is actually that area where the bronchus enters the lung. Often we think of hilum being near the top or the apex of the lung, but that is not always the case. If the tumor is confined to the hilum, use cod 230. If the tumor is confined to the carina, use code 250 (F). And, even though code 300 is a higher code for local, use this code only if there is not enough information to assign the more specific codes of

7 Slide 8 CS EXTENSION NOTE 2 Distance from Carina For tumors involving the ipsilateral main stem bronchus 8 Local Code 200 (T2) Extension to MSB from other parts of the lung and stated to be >= 2cm away If MSB involved and resection was done - assume > 2cm away Code 210 (T2) Distance not stated Surgery not done Regional Code 500 (T3) Extension to MSB from other parts of the lung and stated to be < 2cm away Code 700 (T4) Tumor extends all the way to the carina Note 2 addresses tumors that involve the ipsilateral main stem bronchus (contralateral involvement is coded in CS Mets at Dx). The tumor could have either arisen in the MSB or started somewhere else in the lung and extended to involved the MSB. If the tumor involves the main stem bronchus, we need to determine: Did it arise in the main stem bronchus? If not, did it extend to involve the MSB and if so, how far from the carina is it? The deciding factor for distance is 2cm. Is it less than or equal to 2 cm away or more than 2cm away? Use code 200 if the tumor: extended from other parts of the lung to involve the MSB and it was stated to be >= 2cm away. is confined to the MSB but is 2cm or more AWAY from the carina. involved the MSB and a resection was done. We can assume that the tumor must have been greater than 2cm away if they did surgery (lobectomy, segmental resection, or wedge resection). If the tumor is involving the main stem bronchus but the distance from the carina is not stated, then use code 210. For these cases, surgery would not have been done. If the tumor arose in the MSB or it extended into the MSB and it was stated to be LESS than 2cm away, this is considered more extensive and is coded to code 500. If the tumor extends all the way to involve the carina for other parts of the lung or MSB, use code 700.

8 Slide 9 CS Extension Code 400 (T2) H G 9 (G) Tumor associated with atelectasis or (H) Obstructive pneumonitis that extends to the hilar region but does not involve entire lung; no pleural effusion Review the discussion in the AJCC lung presentation on atelectasis and obstructive pneumonitis. Use code 400 for tumors that are associated with atelectasis (G) or obstructive pneumonitis (H) that extends to the hilar region. This may also be called partial atelectasis or obstructive pneumonitis.

9 Slide 10 CS Extension Code (T2) I (I) Codes Invades visceral pleura 10 If the tumor extends to involve the visceral pleura (I) the codes that apply are codes The exact code depends on whether or not the elastic layer is involved. Review the related paragraph in the AJCC manual in the lung chapter. If this involvement is not mentioned, then use code 430. Code 440 is used when the most extensive tumor involvement is of the pulmonary ligament.

10 Slide 11 CS Extension Code 550 (T3) Code Atelectasis or obstructive pneumonitis of ENTIRE lung 11 If the atelectasis or obstructive pneumonitis involves the ENTIRE lung, then assign code 550. Also in the 500 range are the following: Code Parietal pericardium or pericardium, NOS. This is not the same as a pericardial effusion. This is direct involvement of the actual parietal pericardium. Code Invasion of phrenic nerve

11 Slide 12 CS Extension Codes (T3 or T4 ) Code 600: INFERIOR brachial plexus Chest Wall Diaphragm Pancoast tumor Parietal pleura Code 610: Superior sulcus tumor WITH Encasement of subclavian vessels OR Unequivocal SUPERIOR brachial plexus 12 Review the discussion on Pancoast tumors in the AJCC Manual and Lung presentation. Code 600 includes involvement of the following structures: Brachial plexus, INFERIOR branches or NOS, from superior sulcus Chest (thoracic) wall Diaphragm Pancoast tumor (superior sulcus syndrome), NOS Parietal pleura. Again, this is not the same as a pleural effusion. This is direct extension to the actual parietal pleura. Code 610 includes the following: Superior sulcus tumor WITH encasement of subclavian vessels OR WITH unequivocal involvement of SUPERIOR branches of brachial plexus (C8 or above)

12 Slide 13 CS Extension Code 700 Pulmonary artery/vein involvement by direct extension of the primary tumor - If involvement of artery/veins in the mediastinum, code to If involvement appears to only be within the lung tissue, ignore, and do not code to CS EXTENSION Note 5 Code 700 has several different types of involvement included in it, including most major blood vessels. It is natural that a tumor, even in the lung tissue will likely involve some of the blood vessels with the lung tissue the lung is very vascular. What we are looking for is when the tumor grows beyond the lung tissue into the major blood vessels (such as those listed on the next slide). If so, then code to 700. If not, then code based on the all other elements of the tumor involvement.

13 Slide 14 CS Extension - Major Blood Vessels (T4) Superior vena cava 700 Main pulmonary artery 700 R and L pulmonary artery trunks* 700 R and L superior pulmonary veins* 700 R and L inferior pulmonary veins* 740 Aorta 770 Inferior vena cava * intrapericardial segments This slide provides an expanded list of what is considered major blood vessels. Most of them are coded to code 700 except for the aorta and inferior vena cava.

14 Slide 15 CS EXTENSION - Code 700 versus CS LYMPH NODES - Code 200 Vocal cord paralysis Superior vena cava obstruction Compression of trachea or esophagus These conditions may be related to direct extension of the primary tumor (CS Ext code 700) or to lymph node involvement (CS LN code 200). 15 CS EXTENSION Note 6, CS LYMPH NODES Note 4 Review the discussion on vocal cord paralysis in the AJCC manual and in the lung presentation. Code 700 also includes vocal cord paralysis, superior vena cava obstruction, or compression of the trachea or the esophagus. These conditions may be related to direct extension of the primary tumor or to lymph node involvement. If due to direct extension of the primary tumor, code in the CS Extension data item.

15 Slide 16 Use CS Extension Code 700 (T4) If conditions are due from extension of the primary tumor within the lung Usually, the primary tumor is centrally located In general, code 700 is used for these manifestations 16 As a general guideline, if the tumor is located centrally within the lung itself, and you have any of the conditions listed on the previous slide, you should assign a CS Extension code of 700. If the medical record indicates otherwise, code as indicated. The red hashmark area is the SVC obstruction, etc.

16 Slide 17 Use CS Lymph Nodes Code 200 (N2) If these conditions are clearly not related to direct extension of the primary tumor Usually, the primary tumor is located in the periphery of the lung Therefore, considered mediastinal lymph node involvement 17 If the primary tumor is peripheral and clearly unrelated to the conditions listed on the previous slide, code as mediastinal lymph node involvement (code 200) in CS Lymph Nodes unless there is a statement of involvement by direct extension from the primary tumor.

17 Slide 18 Lung -- CS Lymph Nodes Lymph Nodes 100 Same side Hilar, bronchial, peribronchial, intrapulmonary 200 Same side Subcarinal, mediastinal, others 500 Regional LN, NOS 600 Contralateral Mediastinal, hilar any scalene, any supraclavicular 800 Lymph nodes, NOS 999 Unknown, undocumented Adapted from R S Snell: Clinical Anatomy for Medical Students, 5th ed Note 1. The regional nodes for the lung are listed in codes All other nodes are coded in the Mets at Dx field. Codes 100 and 200 refer to ipsilateral. Code 600 refers to contralateral or bilateral. Code 600 also includes ipsilateral and contralateral scalene and supraclavicular.

18 Slide 19 CS LYMPH NODES NOTES Assume the lymph nodes are involved if the words mass, adenopathy, or enlargement are used to describe any of the lymph nodes named in codes 100 and 200. If ipsilateral, use codes 100 or 200. If bilateral or contralateral, use code No Evidence of Spread or Remaining Examination Negative is sufficient information to consider regional lymph nodes negative (in the absence of any statement about nodes) For LUNG, assume the lymph nodes are involved if the words mass, adenopathy, or enlargement are used to describe any of the lymph nodes named in codes 100 and 200. If the description is of ipsilateral nodes, use codes 100 or 200. If bilateral or contralateral, use code Lung is considered an inaccessible site because the site and the regional lymph nodes cannot be easily palpated. You should record the regional lymph nodes as negative rather than unknown when there is no mention of regional lymph node involvement in the physical examination, pre-treatment diagnostic testing or surgical exploration. No Evidence of Spread or Remaining Examination Negative is sufficient information to consider regional lymph nodes negative (in the absence of any statement about nodes).

19 Slide 20 CS Lymph Nodes Issues If both clinical and pathological assessments of nodes are available, which should be coded? Code the farthest extension Example: RUL wedge resection, one interlobar lymph node involved (code 100). Pre-op CT scan shows right mediastinal node enlarged. Patient referred for RT. Code as 200 mediastinal node(s) involved with Eval code 0 (clinical). 20 Remember that clinical information can be used in assigning the CS data items. The exception is if the pathology examines the same nodes as described clinically and were proven to be negative. For example, if the mediastinal node had also been biopsied and was negative, then only the interlobar nodes should be considered as involved. The CS Extension code will be 100 and the eval code will be 1.

20 Slide 21 CS METS at DX Use Code 00 (not code 99), when there is no information regarding metastasis, but the patient receives the standard treatment for localized or early stage disease Use Code 23 if the contralateral lung is involved AND it is documented as a metastasis Two separate primaries were ruled out Use code 40 if the only indication of distant metastasis is a physician statement in the medical record 21 Cervical Lymph Nodes are Distant!

21 Slide 22 CS Mets at Dx Codes Most pleural effusions are due to tumor Any mention of pleural effusion is coded Codes 15-18: Pleural effusion Code 20: Pericardial effusion Credit line: Lung. In: Greene, F.L., Compton, C.C., Fritz, A.G., et al., editors. AJCC Cancer Staging Atlas. New York: Springer, 2006: American Joint Committee on Cancer. 22 Review the discussion on pleural effusion in the AJCC manual and in the lung presentation. Pleural effusions and pericardial effusions are coded in the CS Mets at Dx data item. The exact code for the pleural effusion involvement depends on whether it is ipsilateral (code 15), contralateral (code 16), both (code 17) or unknown (code 18). Pericardial effusions are assigned code 20.

22 Slide 23 CS Mets at Dx Code 24 Discontinuous pleural tumor foci (I) I Pleura (2 layers) Used with permission: April Fritz, A.Fritz and Associates, LLC Pleural effusion (malignant or NOS) Pleural space 23 This graph provides an example of a discontinuous pleural tumor foci that would be assigned code 24.

23 Slide 24 SSF 1: Separate Tumor Nodules Code 000: None (no mention on imaging or path) Code 010: Identified in SAME lobe ipsilateral lung Code 020: Identified in DIFFERENT lobe ipsilateral lung Code 030: Identified in ipsilateral lung Same and different lobe Code 010 Code 020 Code 040: Identified in ipsilateral lung Unknown if same or different lobe Code 999: Unknown There are only 2 SSF s for the lung. The first SSF records the status of separate tumor nodules in the SAME lung. The information to support the presence of multiple tumors can come from either the clinical workup (imaging) or the pathologic resection. Again, the MP/H rules will have been used to determine that these are the same primary. Any tumor nodules in the OPPOSITE lung will be recorded in CS Mets at Dx. This information was previously recorded in CS Extension. The codes were expanded and moved to SSF1. This information will be needed to derive the stage.

24 Slide 25 SSF 2: Visceral Pleural Invasion (VPI)/Elastic Layer Relevant for peripheral lesions Presence of VPI increases the T category and stage Determined on pathologic examination Codes based on four categories of VPI (PL0-PL3) 25 Review the related information on the elastic layer in the AJCC manual. VPI is relevant for peripheral lung tumors. The presence of visceral pleural invasion by tumors smaller than 3 cm increases the T category and stage. Involvement of the elastic layer can only be determined on pathologic examination. Therefore, this information is based on the results stated on the pathology report. If there was no examination of the pleura, use code 998. The information in the pathology report may be a text description, such as tumor surrounded by lung parenchyma. Or, one of the four categories (PL0-PL3) of visceral pleural invasion may be stated. You should be looking for either of these in the pathology report. Four categories are defined for visceral pleural invasion: PL0 Tumor surrounded by lung parenchyma or invades superficially into pleural connective tissue beneath elastic layer but does not completely traverse elastic layer of pleura (not classified as pleural invasion for staging purposes) PL1 Tumor invades beyond elastic layer (classified as T2) PL2 Tumor extends to surface of the visceral pleura (classified as T2) PL3 Invasion of parietal pleura (classified as T3)

25 Slide 26 Microscopic Anatomy of Visceral Pleura Moving from the visceral pleural surface to the lung parenchyma: 1. a single layer of mesothelial cells 2. a submesothelial connective tissue layer, 3. elastic fibers that usually form a single prominent layer (may also form a second discontinuous layer) 4. a connective tissue layer 26 This slide provides additional information regarding the anatomy of the visceral pleura. The layers moving from the visceral pleural surface to the lung parenchyma are listed in order.

26 Slide 27 Resources AJCC Cancer Staging Manual, Seventh Edition CDC NPCR Education and Training Series Collaborative Staging Manual and Coding Instructions ICD-O-3 SEER Training Website TNM Atlas, 3rd ed. 2nd rev., by B. Spiessl et al. Springer Verlag 1992 The graphics, coding instructions, and other supportive information were provided by the following resources. Slide 28 This Concludes This Presentation Please return to the course content to complete additional case scenarios to reinforce the coding instructions.

AJCC-NCRA Education Needs Assessment Results

AJCC-NCRA Education Needs Assessment Results AJCC-NCRA Education Needs Assessment Results Donna M. Gress, RHIT, CTR Survey Tool 1 Survey Development, Delivery, Analysis THANKS to NCRA for the following work Developed survey with input from partners

More information

Collecting Cancer Data: Lung

Collecting Cancer Data: Lung Collecting Cancer Data: Lung NAACCR 2011 2012 Webinar Series 2/2/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this

More information

Lung 8/7/14. Collecting Cancer Data: Lung NAACCR Webinar Series. August 7, 2014

Lung 8/7/14. Collecting Cancer Data: Lung NAACCR Webinar Series. August 7, 2014 Collecting Cancer Data: Lung 2013 2014 NAACCR Webinar Series August 7, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

NAACCR Webinar Series 1

NAACCR Webinar Series 1 Collecting Cancer Data: Lung 2013 2014 NAACCR Webinar Series August 7, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder:

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder: 1 NAACCR 2015-2016 Webinar Series Collecting Cancer Data: Lung NAACCR 2015 2016 Webinar Series Presented by: Angela Martin amartin@naaccr.org Jim Hofferkamp jhofferkamp@naaccr.org Q&A Please submit all

More information

GUIDELINES FOR CANCER IMAGING Lung Cancer

GUIDELINES FOR CANCER IMAGING Lung Cancer GUIDELINES FOR CANCER IMAGING Lung Cancer Greater Manchester and Cheshire Cancer Network Cancer Imaging Cross-Cutting Group April 2010 1 INTRODUCTION This document is intended as a ready reference for

More information

An Update: Lung Cancer

An Update: Lung Cancer An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology

More information

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment B REAST STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery (DCIS) (LCIS) (Paget s) mi c a b c d TUMOR SIZE:

More information

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment B REAST STAGING FORM Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery (DCIS) (LCIS) (Paget s) mi a b c a b c d TUMOR SIZE: S TAGE

More information

Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung Cancer. Quick Reference Chart and Diagrams

Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung Cancer. Quick Reference Chart and Diagrams CHEST Special Features Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung Cancer Quick Reference Chart and Diagrams Omar Lababede, MD ; Moulay Meziane, MD ; and Thomas Rice, MD, FCCP

More information

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new

More information

The 8th Edition Lung Cancer Stage Classification

The 8th Edition Lung Cancer Stage Classification The 8th Edition Lung Cancer Stage Classification Elwyn Cabebe, M.D. Medical Oncology, Hematology, and Hospice and Palliative Care Valley Medical Oncology Consultants Director of Quality, Medical Oncology

More information

FDG PET/CT in Lung Cancer Read with the experts. Homer A. Macapinlac, M.D.

FDG PET/CT in Lung Cancer Read with the experts. Homer A. Macapinlac, M.D. FDG PET/CT in Lung Cancer Read with the experts Homer A. Macapinlac, M.D. Patient with suspected lung cancer presents with left sided chest pain T3 What is the T stage of this patient? A) T2a B) T2b C)

More information

Bronchogenic Carcinoma

Bronchogenic Carcinoma A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most

More information

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel. Lung NAACCR 2018 2019 WEBINAR SERIES 1 Q&A Please submit all questions concerning the webinar content through the Q&A panel. If you have participants watching this webinar at your site, please collect

More information

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer [Based on WOSCAN NSCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED

More information

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical

More information

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS Exercise 15: CSv2 Data Item Coding Instructions ANSWERS CS Tumor Size Tumor size is the diameter of the tumor, not the depth or thickness of the tumor. Chest x-ray shows 3.5 cm mass; the pathology report

More information

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung

More information

6 th Reprint Handbook Pages AJCC 7 th Edition

6 th Reprint Handbook Pages AJCC 7 th Edition 6 th Reprint Handbook Pages AJCC 7 th Edition AJCC 7 th Edition Errata for 6 th Reprint Table 1 Handbook No Significant Staging Clarifications for 6 th Reprint AJCC 7 th Edition Errata for 6 th Reprint

More information

Chest X-ray Interpretation

Chest X-ray Interpretation Chest X-ray Interpretation Introduction Routinely obtained Pulmonary specialist consultation Inherent physical exam limitations Chest x-ray limitations Physical exam and chest x-ray provide compliment

More information

LungStage. Bringing machine learning to Nuclear Medicine and Lung Cancer using Big Data, Machine Learning and Multicenter Studies

LungStage. Bringing machine learning to Nuclear Medicine and Lung Cancer using Big Data, Machine Learning and Multicenter Studies LungStage Bringing machine learning to Nuclear Medicine and Lung Cancer using Big Data, Machine Learning and Multicenter Studies Medical Team: Bram Stieltjes, MD PhD; Alex Sauter, MD; Gregor Sommer, MD;

More information

Mediastinal Staging. Samer Kanaan, M.D.

Mediastinal Staging. Samer Kanaan, M.D. Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor

More information

Collaborative Stage Site-Specific Instructions - BREAST

Collaborative Stage Site-Specific Instructions - BREAST Slide 1 Collaborative Stage Site-Specific Instructions - BREAST In this presentation, we are going to review the CS Data Items and coding instructions for the breast primary site. Slide 2 Reading Assignments

More information

Syllabus: 6 pages (Page 6 lists corresponding figures for Grant's Atlas 11 th & 12 th Eds.)

Syllabus: 6 pages (Page 6 lists corresponding figures for Grant's Atlas 11 th & 12 th Eds.) PLEURAL CAVITY AND LUNGS Dr. Milton M. Sholley SELF STUDY RESOURCES Essential Clinical Anatomy 3 rd ed. (ECA): pp. 70 81 Syllabus: 6 pages (Page 6 lists corresponding figures for Grant's Atlas 11 th &

More information

Thursday, August 16, :30 AM - 4:30 PM and Friday, August 17, :30 AM 12:00 PM Crowne Plaza 830 Phillips Lane Louisville, KY 40209

Thursday, August 16, :30 AM - 4:30 PM and Friday, August 17, :30 AM 12:00 PM Crowne Plaza 830 Phillips Lane Louisville, KY 40209 KCR newsletter March 2018 KCR 2018 Fall Workshop/Regional Meeting 2018 Tri-State Regional Cancer Registrars Meeting Presented by: Kentucky Cancer Registry, Indiana Cancer Consortium, and Ohio Cancer Incidence

More information

Summary Stage 2018 (SS2018)

Summary Stage 2018 (SS2018) Summary Stage 2018 (SS2018) NAACCR October Webinar October 24, 2018 General Information 2 Summary Stage 2018 1 General Summary Stage is ANATOMICALLY based Unlike AJCC, it does not use the following in

More information

Lecturer: Ms DS Pillay ROOM 2P24 25 February 2013

Lecturer: Ms DS Pillay ROOM 2P24 25 February 2013 Lecturer: Ms DS Pillay ROOM 2P24 25 February 2013 Thoracic Wall Consists of thoracic cage Muscle Fascia Thoracic Cavity 3 Compartments of the Thorax (Great Vessels) (Heart) Superior thoracic aperture

More information

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded. Lung Case Scenario 1 A 54 year white male presents with a recent abnormal CT of the chest. The patient has a history of melanoma, kidney, and prostate cancers. 10/24/13 Chest X-ray: 2.9 cm mass like density

More information

Do you want to be an excellent Radiologist? - Focus on the thoracic aorta on lateral chest image!!!

Do you want to be an excellent Radiologist? - Focus on the thoracic aorta on lateral chest image!!! The lateral chest radiograph: Challenging area around the thoracic aorta!!! Do you want to be an excellent Radiologist? - Focus on the thoracic aorta on lateral chest image!!! Dong Yoon Han 1, So Youn

More information

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma. Case Scenario 1 An 89 year old male patient presented with a progressive cough for approximately six weeks for which he received approximately three rounds of antibiotic therapy without response. A chest

More information

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL ( ) Tx Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging

More information

2018 Implementation: SEER Summary Stage 2018

2018 Implementation: SEER Summary Stage 2018 2018 Implementation: SEER Summary Stage 2018 PRESENTED BY JENNIFER RUHL OCTOBER 24, 2018 10/23/2018 1 Q&A Please submit all questions concerning the content of the webinar through the Q&A panel Submit

More information

Lung Cancer: Determining Resectability

Lung Cancer: Determining Resectability Lung Cancer: Determining Resectability Leslie E. Quint lequint@umich.edu No disclosures Lung Cancer: Determining Resectability AIM: Review imaging features that suggest resectability / unresectability

More information

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh Radiological staging of lung cancer Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh Bronchogenic Carcinoma Accounts for 14% of new cancer diagnoses in 2012. Estimated to kill ~150,000

More information

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH

More information

Collaborative Staging

Collaborative Staging Slide 1 Collaborative Staging Site-Specific Instructions Prostate 1 In this presentation, we are going to take a closer look at the collaborative staging data items for the prostate primary site. Because

More information

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:

More information

Dr. Weyrich G07: Superior and Posterior Mediastina. Reading: 1. Gray s Anatomy for Students, chapter 3

Dr. Weyrich G07: Superior and Posterior Mediastina. Reading: 1. Gray s Anatomy for Students, chapter 3 Dr. Weyrich G07: Superior and Posterior Mediastina Reading: 1. Gray s Anatomy for Students, chapter 3 Objectives: 1. Subdivisions of mediastinum 2. Structures in Superior mediastinum 3. Structures in Posterior

More information

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy. History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12

More information

Role of Surgery in Management of Non Small Cell Lung Cancer. Dr. Ahmed Bamousa Consultant thoracic surgery Prince Sultan Military Medical City

Role of Surgery in Management of Non Small Cell Lung Cancer. Dr. Ahmed Bamousa Consultant thoracic surgery Prince Sultan Military Medical City Role of Surgery in Management of Non Small Cell Lung Cancer Dr. Ahmed Bamousa Consultant thoracic surgery Prince Sultan Military Medical City Introduction Surgical approach Principle and type of surgery

More information

ACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA

ACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA ACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA ACHIEVING EXCELLENCE IN ABSTRACTING LYMPHOMA Recoding Audit Performed in 2009 260 cases audited 17 data items audited per case 4420 possible discrepancies

More information

ACRIN NLST 6654 Primary Lung Cancer. F1/F2 Interval: to (mm-dd-yyyy) 1. Date of diagnosis: (mm-dd-yyyy)

ACRIN NLST 6654 Primary Lung Cancer. F1/F2 Interval: to (mm-dd-yyyy) 1. Date of diagnosis: (mm-dd-yyyy) No. F1/F2 Interval: - - 20 to - - 20 (mm-dd-yyyy) 1. Date of diagnosis: - - 20 (mm-dd-yyyy) 2. Samples recorded: ZP Number S-Number 1) 2) 3) 4) (Refer to Form PX, Column 1. In the rare instance of a diagnosis

More information

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done. Q&A Breast Webinar Q: One of my investigators is interested in knowing when Oncotype DX data collection was implemented. That data is collected in SSFs 22 and 23. I remember that the SSFs for breast were

More information

North of Scotland Cancer Network Clinical Management Guideline for Mesothelioma

North of Scotland Cancer Network Clinical Management Guideline for Mesothelioma THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Mesothelioma [Based on WOSCAN SCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED WHEN PRINTED Document

More information

slide 23 The lobes in the right and left lungs are divided into segments,which called bronchopulmonary segments

slide 23 The lobes in the right and left lungs are divided into segments,which called bronchopulmonary segments Done By : Rahmeh Alsukkar Date : 26 /10/2017 slide 23 The lobes in the right and left lungs are divided into segments,which called bronchopulmonary segments Each segmental bronchus passes to a structurally

More information

Imaging of Lung Cancer: A Review of the 8 th TNM Staging System

Imaging of Lung Cancer: A Review of the 8 th TNM Staging System Imaging of Lung Cancer: A Review of the 8 th TNM Staging System Travis S Henry, MD Associate Professor of Clinical Radiology Cardiac and Pulmonary Imaging Section University of California, San Francisco

More information

ANATOMY OF THE PLEURA. Dr Oluwadiya KS

ANATOMY OF THE PLEURA. Dr Oluwadiya KS ANATOMY OF THE PLEURA Dr Oluwadiya KS www.oluwadiya.sitesled.com Introduction The thoracic cavity is divided mainly into: Right pleural cavity Mediastinum Left Pleural cavity Pleural cavity The pleural

More information

Right lung. -fissures:

Right lung. -fissures: -Right lung is shorter and wider because it is compressed by the right copula of the diaphragm by the live.. 2 fissure, 3 lobes.. hilum : 2 bronchi ( ep-arterial, hyp-arterial ), one artery mediastinal

More information

CT Depiction of Regional Nodal Stations for Lung Cancer Staging

CT Depiction of Regional Nodal Stations for Lung Cancer Staging ownloaded from www.ajronline.org by 37.44.204.189 on 11/24/17 from IP address 37.44.204.189. opyright RRS. For personal use only; all rights reserved T epiction of Regional Nodal Stations for Lung ancer

More information

Mediastinum It is a thick movable partition between the two pleural sacs & lungs. It contains all the structures which lie

Mediastinum It is a thick movable partition between the two pleural sacs & lungs. It contains all the structures which lie Dr Jamila EL medany OBJECTIVES At the end of the lecture, students should be able to: Define the Mediastinum. Differentiate between the divisions of the mediastinum. List the boundaries and contents of

More information

Non small cell Lung Cancer

Non small cell Lung Cancer Non small cell Lung Cancer The 13th refresher course for residents in radiation oncology Jiraporn Setakornnukul, M.D. Radiation oncology division, Radiology department Siriraj Hospital, Mahidol University

More information

Kidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification

Kidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification Kidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification A1: Yes. See below. I don't think it will have a start date. Clarification

More information

Collaborative Staging Manual and Coding Instructions Part II: Primary Site Schema

Collaborative Staging Manual and Coding Instructions Part II: Primary Site Schema C44.0-C44.9, C51.0-C51.2, C51.8-C51.9, C60.0-C60.2, C60.8-C60.9, C63.2 (M-8720-8790) C44.0 Skin of lip, NOS C44.1 Eyelid C44.2 External ear C44.3 Skin of ear and unspecified parts of face C44.4 Skin of

More information

Histopathology of NSCLC, IHC markers and ptnm classification

Histopathology of NSCLC, IHC markers and ptnm classification ESMO Preceptorship on Non-Small Cell Lung Cancer November 15 th & 16 th 2017 Singapore Histopathology of NSCLC, IHC markers and ptnm classification Prof Keith M Kerr Department of Pathology, Aberdeen University

More information

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific

More information

2018 Summary Stage PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

2018 Summary Stage PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018 1 2018 Summary Stage PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgement Jennifer Ruhl, NCI SEER 3 Introduction 2018 SUMMARY STAGE 2018 Summary Stage 4 First update since 2001

More information

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ] CS Tumor Size Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ] Note: the specific tumor size as documented in the medical record. If the ONLY information regarding tumor size is the physician's

More information

Lung Cancer Staging: The Revised TNM Classification

Lung Cancer Staging: The Revised TNM Classification Norwegian Society of Thoracic Imaging Oslo, October 2011 Lung Cancer Staging: The Revised TNM Classification Sujal R Desai King s College Hospital, London Lung Cancer The Scale of the Problem Leading cause

More information

Coding Pitfalls 9/11/14

Coding Pitfalls 9/11/14 Coding Pitfalls 2013 2014 NAACCR Webinar Series September 11, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

Dana Alrafaiah. - Moayyad Al-Shafei. -Mohammad H. Al-Mohtaseb. 1 P a g e

Dana Alrafaiah. - Moayyad Al-Shafei. -Mohammad H. Al-Mohtaseb. 1 P a g e - 6 - Dana Alrafaiah - Moayyad Al-Shafei -Mohammad H. Al-Mohtaseb 1 P a g e Quick recap: Both lungs have an apex, base, mediastinal and costal surfaces, anterior and posterior borders. The right lung,

More information

Case Conference: Post-Operative Radiotherapy for Non-Small Cell Lung Cancer. Doug Rahn 6/1/12

Case Conference: Post-Operative Radiotherapy for Non-Small Cell Lung Cancer. Doug Rahn 6/1/12 Case Conference: Post-Operative Radiotherapy for Non-Small Cell Lung Cancer Doug Rahn 6/1/12 Outline I. Presentation of Case II. Epidemiology III. Staging IV. Review of Literature V. Recommendations VI.

More information

Chest and cardiovascular

Chest and cardiovascular Module 1 Chest and cardiovascular A. Doss and M. J. Bull 1. Regarding the imaging modalities of the chest: High resolution computed tomography (HRCT) uses a slice thickness of 4 6 mm to identify mass lesions

More information

Theme 30. Structure, topography and function of the lungs and pleura. Mediastinum and its contents. X -ray films digestive and respiratory systems.

Theme 30. Structure, topography and function of the lungs and pleura. Mediastinum and its contents. X -ray films digestive and respiratory systems. Theme 30. Structure, topography and function of the lungs and pleura. Mediastinum and its contents. X -ray films digestive and respiratory systems. STRUCTURE, TOPOGRAPHY AND FUNCTІON OF LUNGS AND PLEURA.

More information

Identify the lines used in anatomical surface descriptions of the thorax. median line mid-axillary line mid-clavicular line

Identify the lines used in anatomical surface descriptions of the thorax. median line mid-axillary line mid-clavicular line L 14 A B O R A T O R Y Thorax THORACIC WALL Identify the lines used in anatomical surface descriptions of the thorax. median line mid-axillary line mid-clavicular line Identify the surface landmarks of

More information

Lung CS Tumor Size Note: Do not code size of hilar mass unless primary is stated to be in the hilum. Code Description

Lung CS Tumor Size Note: Do not code size of hilar mass unless primary is stated to be in the hilum. Code Description Lung C34.0-C34.3, C34.8-C34.9 C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung C34.3 Lower lobe, lung C34.8 Overlapping lesion of lung C34.9 Lung, NOS Note: Laterality must be coded for

More information

MEDIASTINAL STAGING surgical pro

MEDIASTINAL STAGING surgical pro MEDIASTINAL STAGING surgical pro Paul E. Van Schil, MD, PhD Department of Thoracic and Vascular Surgery University of Antwerp, Belgium Mediastinal staging Invasive techniques lymph node mapping cervical

More information

CS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1.

CS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1. CS Evaluation Fields Education and Training Team Collaborative Stage Data Collection System Version 02.03.02 (Effective date: 1/1/2011) Outline of Presentation Purpose AJCC TNM Classification Eval data

More information

CS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval

CS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval C70.0, C71.0-C71.9 C70.0 Cerebral meninges C71.0 Cerebrum C71.1 Frontal lobe C71.2 Temporal lobe C71.3 Parietal lobe C71.4 Occipital lobe C71.5 Ventricle, NOS C71.6 Cerebellum, NOS C71.7 Brain stem C71.8

More information

PLEURAE and PLEURAL RECESSES

PLEURAE and PLEURAL RECESSES PLEURAE and PLEURAL RECESSES By Dr Farooq Aman Ullah Khan PMC 26 th April 2018 Introduction When sectioned transversely, it is apparent that the thoracic cavity is kidney shaped: a transversely ovoid space

More information

Lecture 2: Clinical anatomy of thoracic cage and cavity II

Lecture 2: Clinical anatomy of thoracic cage and cavity II Lecture 2: Clinical anatomy of thoracic cage and cavity II Dr. Rehan Asad At the end of this session, the student should be able to: Identify and discuss clinical anatomy of mediastinum such as its deflection,

More information

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False Quiz 1 1. Which of the following are risk factors for esophagus cancer. a. Obesity b. Gastroesophageal reflux c. Smoking and Alcohol d. All of the above 2. Adenocarcinoma of the distal stomach has been

More information

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.

More information

Pulmonary Neoplasms & Chest Disorders Ahmed Mahmoud

Pulmonary Neoplasms & Chest Disorders Ahmed Mahmoud Pulmonary Neoplasms & Chest Disorders Ahmed Mahmoud Lung Ca ;Pathological types Adenocarcinoma More common in females Peripheral location Spread mainly by blood(brain..) Incidence is increasing (the most

More information

Q&A for Collecting Cancer Data: Unusual Sites and Histologies Thursday, October 1, 2015

Q&A for Collecting Cancer Data: Unusual Sites and Histologies Thursday, October 1, 2015 Q&A for Collecting Cancer Data: Unusual Sites and Histologies Thursday, October 1, 2015 Q1: why can t we use pos pleural effusion to stage t value? A: Pleural effusion in Pleural Mesothelioma does not

More information

9/17/2013. Presentation Outline. Overview

9/17/2013. Presentation Outline. Overview FCDS 2013 Educational Webcast Series September 19, 2013 Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR FCDS QC Staff Presentation Outline Overview of Lung Cancer Signs, Symptoms and Risk Factors Anatomy

More information

FCDS 2013 Educational Webcast Series September 19, Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR FCDS QC Staff

FCDS 2013 Educational Webcast Series September 19, Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR FCDS QC Staff FCDS 2013 Educational Webcast Series September 19, 2013 Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR FCDS QC Staff Presentation Outline Overview of Lung Cancer Signs, Symptoms and Risk Factors Anatomy

More information

NEW JERSEY STATE CANCER REGISTRY

NEW JERSEY STATE CANCER REGISTRY NEW JERSEY STATE CANCER REGISTRY SEER Summary Stage 2000/SEER Summary Stage 2018 Comparison Guide Updated 5-16-18 SEER Summary Stage 2000/SEER Summary Stage 2018 Comparison Developed by the New Jersey

More information

Large veins of the thorax Brachiocephalic veins

Large veins of the thorax Brachiocephalic veins Large veins of the thorax Brachiocephalic veins Right brachiocephalic vein: formed at the root of the neck by the union of the right subclavian & the right internal jugular veins. Left brachiocephalic

More information

THE DESCENDING THORACIC AORTA

THE DESCENDING THORACIC AORTA Intercostal Arteries and Veins Each intercostal space contains a large single posterior intercostal artery and two small anterior intercostal arteries. The anterior intercostal arteries of the lower spaces

More information

Radiological Anatomy of Thorax. Dr. Jamila Elmedany & Prof. Saeed Abuel Makarem

Radiological Anatomy of Thorax. Dr. Jamila Elmedany & Prof. Saeed Abuel Makarem Radiological Anatomy of Thorax Dr. Jamila Elmedany & Prof. Saeed Abuel Makarem Indications for Chest x - A chest x-ray may be used to diagnose and plan treatment for various conditions, including: Diseases/Fractures

More information

Respiratory Interactive Session. Elaine Borg

Respiratory Interactive Session. Elaine Borg Respiratory Interactive Session Elaine Borg Case 1 Respiratory Cytology 55 year old gentleman Anterior mediastinal mass EBUS FNA Case 1 Respiratory Cytology 55 year old gentleman with anterior mediastinal

More information

Multiple Primary Quiz

Multiple Primary Quiz Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult

More information

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012 Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012 Q: Will sticky notes be transferrable from the previous electronic version of CS to the updated version? A: It is our

More information

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue Case Scenario 1 Oncology Consult: Patient is a 51-year-old male with history of T4N3 squamous cell carcinoma of tonsil status post concurrent chemoradiation finished in October two years ago. He was hospitalized

More information

International Association for the Study of Lung Cancer lymph node map Lymph node stations Imaging CT

International Association for the Study of Lung Cancer lymph node map Lymph node stations Imaging CT Review of the International Association for the Study of Lung Cancer Lymph Node Classification System Localization of Lymph Node Stations on CT Imaging Hamza Jawad, MBBS a, Arlene Sirajuddin, MD b, Jonathan

More information

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery. Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This

More information

This is not a required assignment but it is recommended.

This is not a required assignment but it is recommended. SU 12 Name: This is not a required assignment but it is recommended. BIO 116 - Anatomy & Physiology II Practice Assignment 2 - The Respiratory and Cardiovascular Systems 1. The exchange of oxygen and carbon

More information

10/14/2018 Dr. Shatarat

10/14/2018 Dr. Shatarat 2018 Objectives To discuss mediastina and its boundaries To discuss and explain the contents of the superior mediastinum To describe the great veins of the superior mediastinum To describe the Arch of

More information

Lung & Pleura. The Topics :

Lung & Pleura. The Topics : Lung & Pleura The Topics : The Trachea. The Bronchi. The Brochopulmonary Segments. The Lungs. The Hilum. The Pleura. The Surface Anatomy Of The Lung & Pleura. The Root & Hilum. - first of all, the lung

More information

ACTIVITY 9: BLOOD AND HEART BLOOD

ACTIVITY 9: BLOOD AND HEART BLOOD ACTIVITY 9: BLOOD AND HEART OBJECTIVES: 1) How to get ready: Read Chapters 21 & 22, McKinley et al., Human Anatomy, 4e. All text references are for this textbook. Read dissection instructions BEFORE YOU

More information

Mediastinum and pericardium

Mediastinum and pericardium Mediastinum and pericardium Prof. Abdulameer Al-Nuaimi E-mail: a.al-nuaimi@sheffield.ac.uk E. mail: abdulameerh@yahoo.com The mediastinum: is the central compartment of the thoracic cavity surrounded by

More information

Surgical management of lung cancer

Surgical management of lung cancer Surgical management of lung cancer Nick Roubos FRACS Cardiothoracic Surgeon Box Hill Hospital, Epworth Eastern Thoracic Oncology Non Small Cell Lung Cancer (NSCLC) Small Cell Lung Cancer Mesothelioma Pulmonary

More information

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX MP/H Quiz 1. A patient presented with a prior history of squamous cell carcinoma of the base of the tongue. The malignancy was originally diagnosed

More information

Read Chapters 21 & 22, McKinley et al

Read Chapters 21 & 22, McKinley et al ACTIVITY 9: BLOOD AND HEART OBJECTIVES: 1) How to get ready: Read Chapters 21 & 22, McKinley et al., Human Anatomy, 5e. All text references are for this textbook. Read dissection instructions BEFORE YOU

More information

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux. Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately

More information

ONLINE CONTINUING EDUCATION ACTIVITY

ONLINE CONTINUING EDUCATION ACTIVITY ONLINE CONTINUING EDUCATION ACTIVITY Take free quizzes online at acsjournals.com/ce ARTICLE TITLE: Lung Cancer Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual

More information

NAACCR Hospital Registry Webinar Series

NAACCR Hospital Registry Webinar Series NAACCR Hospital Registry Webinar Series Shannon Vann, CTR Jim Hofferkamp, CTR Webinar Series 1 Abstracting Larynx Cancer Incidence & Treatment Data Estimated new cases and deaths from laryngeal cancer

More information

Robotic-assisted right upper lobectomy

Robotic-assisted right upper lobectomy Robotic Thoracic Surgery Column Robotic-assisted right upper lobectomy Shiguang Xu, Tong Wang, Wei Xu, Xingchi Liu, Bo Li, Shumin Wang Department of Thoracic Surgery, Northern Hospital, Shenyang 110015,

More information